Medical Schemes Affordability Crisis: Insights ...

By João L. Carapinha

October 31, 2025

The CMS Annual Report 2024/25 highlights significant medical schemes affordability challenges in South Africa, where relevant healthcare expenditure per beneficiary surged by 8.70% year-on-year, far outpacing both contribution growth and general i...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
NHS Productivity Gains at Risk: Balancing Innovation and Cost Control
Collaboration Cardiac Surgery: Boosting Surgical Volumes Through Multidiscipl...
MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Onc...
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services
The Value of Self-Care in Public Health: Insights and Implications for Europe
Impending Net Drug Price Transparency Regulation in the U.S.
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
NICE Approves Transformative Multiple Myeloma Treatment
Telemedicine Growth Strategies: Insights from the WHO European Region